CMA1

chymase 1, the group of Granule associated serine proteases of immune defence

Basic information

Region (hg38): 14:24505353-24508265

Links

ENSG00000092009NCBI:1215OMIM:118938HGNC:2097Uniprot:P23946AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CMA1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CMA1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
15
clinvar
1
clinvar
16
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 15 1 0

Variants in CMA1

This is a list of pathogenic ClinVar variants found in the CMA1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
14-24505556-T-G not specified Uncertain significance (Mar 19, 2024)3267955
14-24505611-C-T not specified Uncertain significance (Jan 26, 2022)2351455
14-24505634-C-G not specified Uncertain significance (May 31, 2023)2553416
14-24506060-C-T not specified Uncertain significance (May 05, 2023)2523873
14-24506065-C-A not specified Uncertain significance (Dec 28, 2023)2384703
14-24506081-G-A not specified Uncertain significance (Jul 06, 2021)2385576
14-24506119-A-G not specified Uncertain significance (Nov 09, 2022)2212082
14-24506140-T-C not specified Uncertain significance (Dec 07, 2021)2265400
14-24506158-G-A not specified Uncertain significance (Oct 06, 2023)3146196
14-24506160-C-A not specified Uncertain significance (Jun 17, 2024)3267957
14-24506194-C-T not specified Uncertain significance (Sep 14, 2022)2204267
14-24506558-C-A not specified Uncertain significance (Feb 28, 2024)3146195
14-24506604-C-T not specified Likely benign (Nov 03, 2023)3146194
14-24507388-G-T not specified Uncertain significance (Oct 03, 2022)2315924
14-24507392-C-T EBV-positive nodal T- and NK-cell lymphoma Likely benign (-)2681201
14-24507420-T-C not specified Uncertain significance (Dec 03, 2021)2263950
14-24507429-C-G Likely benign (Mar 28, 2018)708801
14-24507430-G-T not specified Uncertain significance (Dec 26, 2023)3146193
14-24507488-G-C not specified Uncertain significance (Jul 06, 2021)2234943
14-24507495-C-T not specified Uncertain significance (Jun 27, 2022)2361729
14-24508192-G-C not specified Uncertain significance (May 20, 2024)3267954
14-24508196-A-G not specified Uncertain significance (Apr 08, 2024)3267953
14-24508216-G-C not specified Uncertain significance (Mar 29, 2024)3267956

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CMA1protein_codingprotein_codingENST00000250378 52913
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
7.59e-90.043112501447141257320.00286
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.752011421.410.000007821589
Missense in Polyphen7651.7951.4673604
Synonymous-1.907455.91.320.00000300519
Loss of Function-0.806118.471.303.56e-7112

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.006020.00604
Ashkenazi Jewish0.000.00
East Asian0.03140.0314
Finnish0.00009240.0000924
European (Non-Finnish)0.00007950.0000791
Middle Eastern0.03140.0314
South Asian0.0003920.000392
Other0.001470.00147

dbNSFP

Source: dbNSFP

Function
FUNCTION: Major secreted protease of mast cells with suspected roles in vasoactive peptide generation, extracellular matrix degradation, and regulation of gland secretion.;
Pathway
Agents Acting on the Renin-Angiotensin System Pathway, Pharmacodynamics;Renin-angiotensin system - Homo sapiens (human);ACE Inhibitor Pathway, Pharmacodynamics;Lung fibrosis;ACE Inhibitor Pathway;Signal Transduction;Peptide hormone metabolism;Metabolism of proteins;Metabolism of Angiotensinogen to Angiotensins;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Degradation of the extracellular matrix;Signaling by SCF-KIT;Signaling by Receptor Tyrosine Kinases (Consensus)

Recessive Scores

pRec
0.626

Intolerance Scores

loftool
0.477
rvis_EVS
0.2
rvis_percentile_EVS
67.19

Haploinsufficiency Scores

pHI
0.131
hipred
N
hipred_score
0.216
ghis
0.403

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.138

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cma1
Phenotype
hematopoietic system phenotype; immune system phenotype;

Gene ontology

Biological process
angiotensin maturation;extracellular matrix disassembly;midbrain development;basement membrane disassembly;positive regulation of angiogenesis;interleukin-1 beta biosynthetic process;regulation of inflammatory response;cellular response to glucose stimulus
Cellular component
extracellular region;extracellular space;cytoplasm;secretory granule;collagen-containing extracellular matrix
Molecular function
endopeptidase activity;serine-type endopeptidase activity;serine-type peptidase activity;peptide binding